Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Ellipsys Vascular Access System

The new solution for AV fistula creation

The Ellipsys™ Vascular Access System is the surgery-free alternative to AV fistula creation.

The Ellipsys™ Vascular Access System

fistula

Designed for end-stage renal disease patients requiring hemodialysis, the Ellipsys™ Vascular Access System is a unique single-catheter, non-surgical option for physicians to create an arteriovenous (AV) fistula.

See how EllipsysTM Vascular Access System works

  • Fast and efficient – the procedure can be completed in just 30 minutes1

  • Reproducible and minimally invasive1

  • Requires no incision, implant, or suture – innovative percutaneous  AVF technology2

  • Patients leave with a single puncture – no scars, no lumps or bumps, less risk of complications3

The Ellipsys™ System benefits from a strong evidence base:

  • Minimally invasive
  • Highly effective
numbers

Back to top

Transform AV fistula creation

The Ellipsys™ System offers:

  • Patented tissue fusion technology, enabling immediate, minimally invasive creation of permanently fused anastomosis4

  • A track record of achievement in over 3,000 procedures in several settings5

Peer-reviewed manuscripts from Germany and France comparing the Ellipsys™ System to surgical AVF creation have demonstrated its effectiveness:6,7

  • There was no difference in secondary patency of endoAVF compared to sAVF through 12 or 24 months6
  • Procedure time with Ellipsys™ System was significantly shorter with endoAVF compared to sAVF7
Download brochure
f

Back to top

Hear what the experts say

Watch the video to learn about the EllipsysTM Vascular Access System - presentation by Drs. Alex Mallios and Robert Shahverdyan.

Optimize the care continuum

Learn how to optimize the entire care continuum for endovascular AVF creation including patient selection, fistula creation, maturation, and cannulation.

See the process
Doctor patient portrait

Additional resources

Patient information

Download our patient brochure
to learn more.

Download now
additional resources

Medical education

Explore our vast education offering and register to the sessions of your interest.

Explore now

Back to top

A complementary range of vascular access and renal care solutions

With the Ellipsys™ Vascular Access System, we have solutions to support end-stage renal disease patients across the vascular access care continuum.

Complementary AV fistula
maintenance solutions include:

fortex
Fortrex™ PTA Balloon
in.pact
IN.PACT™ Admiral™ DCB†

Support for you and your patients

We provide a full range of education
and resources for your patients.

Contact us

Back to top

† The approved product name for the drug-coated balloon is IN.PACT™ Admiral™ Paclitaxel-coated PTA Balloon Catheter.​

References

1

 Hull JE, Jennings WC, Cooper RI, Waheed U, Schaefer ME, Narayan R. The Pivotal Multicenter Trial of Ultrasound-Guided Percutaneous Arteriovenous Fistula​ Creation for Hemodialysis Access. J Vasc Interv Radiol. February 2018;29(2):149-158.e5​.

2

Frankel A. Temporary Access and Central Venous Catheters. Eur J Vasc Endovasc Surg. April 2006; (31), 417-422​

3

Mallios A, Bourquelot P, Franco G, et al. Midterm results of percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access System, technical​ recommendations, and an algorithm for maintenance. J Vasc Surg. December 2020;72(6):2097-2106.​

4

Beathard GA, Litchfield T, Jennings WC. Two-year cumulative patency of endovascular arteriovenous fistula. J Vasc Access. May 2020;21(3):350-356.​

5

Data on file at Medtronic as per claims matrix UC202304488EN - Ellipsys.

6

Harika et al. Comparison of surgical versus percutaneously created arteriovenous hemodialysis fistulas. JVS Feb 2021.​

7

Shahverdyan R et al. Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas. AJKD March 2021.​